Search Results - "Leibman, N.F"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center by Bergman, P.J., Camps-Palau, M.A., McKnight, J.A., Leibman, N.F., Craft, D.M., Leung, C., Liao, J., Riviere, I., Sadelain, M., Hohenhaus, A.E., Gregor, P., Houghton, A.N., Perales, M.A., Wolchok, J.D.

    Published in Vaccine (22-05-2006)
    “…Canine malignant melanoma (CMM) is an aggressive neoplasm treated with surgery and/or fractionated RT; however, metastatic disease is common and…”
    Get full text
    Journal Article
  2. 2

    Xenogeneic Murine Tyrosinase DNA Vaccine for Malignant Melanoma of the Digit of Dogs by Manley, C.A., Leibman, N.F., Wolchok, J.D., Rivière, I.C., Bartido, S., Craft, D.M., Bergman, P.J.

    Published in Journal of veterinary internal medicine (01-01-2011)
    “…Background: Malignant melanoma of dogs is a highly aggressive neoplasm and is the 2nd most common digit tumor. Metastatic disease is a common sequela for which…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Cytological comparison of fine-needle aspirates of liver and spleen of normal dogs and of dogs with cutaneous mast cell tumours and an ultrasonographically normal appearing liver and spleen by Finora, K, Leibman, N.F, Fettman, M.J, Powers, B.E, Hackett, T.A, Withrow, S.J

    Published in Veterinary & comparative oncology (01-09-2006)
    “…Staging of dogs with cutaneous mast cell tumours (MCTs) is an important diagnostic step. Aspiration of the liver and the spleen is often part of routine…”
    Get full text
    Journal Article